Posts

What happens when abiraterone stops working?

When abiraterone, a drug commonly used to treat metastatic prostate cancer, stops working, it means the cancer has become resistant to the drug. Abiraterone works by blocking the production of androgens (male hormones such as testosterone), which prostate cancer cells often rely on to grow. However, over time, prostate cancer cells can adapt and adopt ways to grow despite low androgen levels. When this happens, the cancer can continue to progress, and the following things can happen: Cancer progression: The tumor may begin to grow again, causing an increase in symptoms or an increase in PSA (prostate-specific antigen) levels, a marker used to monitor the progression of prostate cancer and Abiraterone Price in Malaysia . Development of resistance: This resistance can be caused by several factors, including: Alternative androgen production: Prostate cancer cells may develop mechanisms to produce their own androgens or activate androgen receptors even without external androgens. Mutations...
Image
 How effective is abiraterone for prostate cancer? Clinical studies have shown that abiraterone can significantly improve overall survival and delay disease progression. It is often used in combination with prednisone to help manage side effects and increase its effectiveness and Abiraterone Price in Malaysia . For patients with early-stage disease, such as metastatic hormone-sensitive prostate cancer, abiraterone has also demonstrated benefits in combination with hormone therapy. However, like any treatment, effectiveness can vary based on individual factors such as overall health, cancer stage, and previous treatments. Always consult a healthcare professional for personalized information and recommendations. Does abiraterone cause high cholesterol? Yes, abiraterone can potentially cause an increase in cholesterol levels. Clinical studies have reported that some patients experience high levels of cholesterol and other lipids while taking the medication. This side effect is thought...